Parkinson DiseasePD-GPCNCT04054856
Sensor-supported Classification of Gait Patterns in Everyday Movement of Patients With Parkinson's Disease
A study testing Body Sensor Network in people with Parkinson Disease, run by RWTH Aachen University at 1 site in Germany.
Trial summary
Within this study we conduct long-term measurements on Parkinson patients using a three sensor IMU setup: one sensor is located at the wrist, one sensor at the belt/ in the pocket and one sensor is worn as a pendant. Read more about this study
- Who is it for?
- Ages 60 years and olderHealthy volunteers can take part
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- Body Sensor Network
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3 participants
- Where
- 1 siteGermany
- Study dates
- 16 Dec 2019to 6 Mar 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- patients with Parkinson's disease
- patients undergoing outpatient or inpatient treatment at the UKA
- age of majority (age > 60 years)
- written declaration of consent
- persons who are legally competent and mentally able to follow the instructions of the study personnel
- subjects of advanced age without neurological, psychiatric or other relevant internal diseases (age > 60 years)
Show all 9Show fewer
- age of majority
- written declaration of consent
- persons who are legally competent and mentally able to follow the instructions of the study staff
Who cannot join
- persons with currently known instabilities of the musculoskeletal system (high fall potential)
- persons with electrophobia (fear of electrical devices)
- persons wearing electrically active implants (e.g. cardiac or brain pacemakers)
- persons with neurological (except PD) or psychiatric disorders
- persons with relevant internal diseases (e.g. severe heart failure)
- persons who are accommodated in an establishment on official or judicial instruction
Show all 10Show fewer
- persons who are dependent on or have an employment relationship with the sponsor or investigator
- simultaneous participation in another interventional clinical trial
- alcohol or drug abuse
- lack of compliance
Trial locations and contacts
1 site in 1 country.
Germany1 site
Department of Neurology, University Hospital Aachen
Aachen, North Rhine-Westphalia, 52074
About this study
Within this study we conduct long-term measurements on Parkinson patients using a three sensor IMU setup: one sensor is located at the wrist, one sensor at the belt/ in the pocket and one sensor is worn as a pendant. Before and after each long-term measurement phase (5 days within 6-8 weeks) we perform an UPDRS to identify changes in everyday life behaviour that correlate with UPDRS trends (especially part 3).
Read the detailed description
The aim of the study is to collect a database for the development of algorithms for the classification of everyday movement patterns of PD patients with the underlying sensor concepts. From the recorded movement data of PD patients and healthy volunteers (reference basis), characteristic features will be derived which could allow a distinction between pathological and unobtrusive non-disturbed movement patterns (e.g. on/off-state classification) and an assessment of the fall potential.
Study Timeline
The present study will be carried out in three, partly successive stages. The first two stages are measurements with the presented system during a medical examination (or afterwards) under annotation of certain motor exercises to determine the state of health of the patient or test person. In order to generate a sufficient reference database of comparable movement patterns, a series of measurements with subjects of a similar average age is carried out in parallel with the same sensor configuration and the same motor exercises. The third part of the study includes measurements in the home environment of Parkinson's patients. These measurements are used to identify the previously annotated movement patterns in the everyday life of the patient of the same previously included patient group. The individual stages of the study comprise in detail:
- Acquisition of patients/test persons The voluntary participants of this study will be recruited during the doctor's visit. The group of study participants with PD may consist of both outpatients and inpatients with Parkinson's disease (see also sub-section 4). The group of healthy volunteers is recruited from relatives or acquaintances of the patients or by request of uninvolved persons (in each case without motor impairments, see inclusion/exclusion criteria). If a patient or subject is suitable to participate in the study based on the inclusion and exclusion criteria, he or she will be informed and sign the consent form so that he or she can be included in the study. Each study participant receives an individual identification number, which is used to identify all other patient-specific documents.
- Annotation Measurements Parkinson Patients As soon as the patients have agreed to voluntarily participate in the study, the current disease status is first determined during a medical examination on the basis of a UPDRS and documented for the study evaluation. Following this, typical exercises for recording motor deficits are carried out. For this purpose, the patient is equipped with the intended sensor system and instructed in its use. The sensor system comprises three different sensor nodes, which are placed around the wrist, as a collar and in the trouser pocket. The wrist sensor is fixed to the patient's wrist by a flexible strap with a Velcro fastener. The neck sensor is positioned under the upper layer of clothing and hung around the neck by means of a special textile collar (approx. 35g). The third sensor knot has no special fastening device and is carried loosely in the trouser pocket. The attachment of the sensors is illustrated in Fig. 1. The movement data are recorded parallel to the exercises and extensively annotated according to the exercise characteristics. The exercises contain typical everyday movement patterns, which are to be identified in the further course of the study in the measurements in the domestic environment (subitem 3) and used for the evaluation of the state of health. These include among others: sit-to-stand test (STS), five-times-sit-to-stand test (5STS), sit-to-walk test (STW) or timed-up-and-go test (TUG), normal walking, climbing stairs, and handwriting.
- Annotation measurements reference group The volunteers participating in the study will be equipped with the same measuring equipment as the group of Parkinson's patients. The measurements on subjects of comparable average age serve as a reference to physiological movement sequences during the same motor exercises. On the one hand, the aim is to cover as broad a spectrum as possible for the classification of the various movement patterns. On the other hand, the data are to be used to identify pathological features that distinguish them from healthy movement patterns.
- Movement monitoring in the domestic/clinical environment of patients The group of outpatient/inpatient Parkinson's patients also take part in a long-term measurement in the domestic/clinical environment. Following the first motor examination, 5 consecutive measurements over a longer period of one day each are carried out in this section of the study. The equipment with the required measuring electronics takes place at the patient's place of residence/ in the clinic. In addition to the three previously used sensor nodes, the patient is equipped with a further node for recording on an SD card, which is also carried in the trouser pocket (approx. 35g). The SD card is written using low-level access and an internally developed protocol. This prevents third parties from accessing the transaction data. The measuring equipment is handed over on the morning of the scheduled day by a co-investigator. The patient is equipped with the system and the necessary handling of the sensor nodes is explained over the course of the day. As a daily form dependent annotated reference, the motor exercises mentioned under 2. are repeated - as far as possible in the patient's home environment / in the clinic. The patient is asked to keep an event log of the day at his own discretion and ability. On the evening of the same day, the measuring system is received again on site by a co-investigator. Any complications or questions regarding the further study protocol will be received, documented and, if necessary, reported to the study director.
- Final motor examination After completion of the third part of the study, each participant undergoes a final medical examination. This will take place following the nearest routine visit. In this examination, the motor exercises are carried out again in order to establish a basis for comparison with the initial situation (UPDRS Trend).
- Conditions
- Parkinson Disease
- Being tested
- Body Sensor Network
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Body Sensor NetworkDevice
The "Integrated Posture and Activity NEtwork by Medit Aachen (IPANEMA)" Body Sensor Network (BSN) is a wireless sensor network with several sensor nodes. A sensor node consists of a base unit equipped with different sensor modalities: Acceleration sensor, Rotation rate sensor, Air pressure sensor, Photoplethysmography (PPG, optional), Galvanic Skin Response (GSR, optional) measurement. The sensor data is transmitted via a wireless 433/868 MHz ISM band radio link to the central radio node. From there, the data is transferred via a Bluetooth connection to a laptop or PC for processing. Three sensors are attached 1) to the wrist with a flexible Velcro strap, 2) hung around the neck on a specially designed collar and 3) worn loosely in the trouser pocket without further fixation or at the belt. The respective sensors are located in a closed, ergonomically shaped housing (size 70x40x20mm^3, approx. 35g) and have no electrically conductive contact to the skin surface of the test person.
| Study group | Role | What they receive |
|---|---|---|
| Patients with Morbus Parkinson | Other | Not described Receives: Device: Body Sensor Network |
| Healthy Subjects | Other | Not described Receives: Device: Body Sensor Network |
What is being measured
The primary outcome is the main question the study is designed to answer.
Disease Assessment with Wearable Movement Sensors
The Unified Parkinson's Disease Rating Scale (UPDRS) will be conducted in two consecutive clinical visits (6-12 weeks) or during an inpatient stay (5 days+). In between we conduct 5 days of long-term monitoring for each patient using a wearable movement sensor system. Outcome measures of the system (overall activity, stride time, stride variability, gait symmetry, symptom appearance, etc.) will be correlated with the UPDRS trend.
Measured: 5 days -12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Aug 2019
- Study start16 Dec 2019
- Primary completion20 Apr 2022
- Study completion6 Mar 2023
Why it stopped: Due to COVID-19 pandemic and new regulatory requirements
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 3 participants (actual)
Sponsor and investigators
- Lead sponsor
- RWTH Aachen University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Kathrin Reetz, Prof. Dr., Principal investigator, Departmet of Neurology, University Clinic Aachen, Germany
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04054856
- Sponsor's protocol ID
- 17-041
- Acronym
- PD-GPC
- Status last verified
- Mar 2023
- First submitted
- 2 Jul 2019
- Last updated
- 3 Apr 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Dennison AC, Noorigian JV, Robinson KM, Fisman DN, Cianci HJ, Moberg P, Bunting-Perry L, Martine R, Duda J, Stern MB. Falling in Parkinson disease: identifying and prioritizing risk factors in recurrent fallers. Am J Phys Med Rehabil. 2007 Aug;86(8):621-32. doi: 10.1097/PHM.0b013e311611583.
PubMed 17667192Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, Bloem BR. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007 Oct 15;22(13):1892-900. doi: 10.1002/mds.21598.
PubMed 17588236Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):721-5. doi: 10.1136/jnnp.72.6.721.
PubMed 12023412Stolze H, Klebe S, Zechlin C, Baecker C, Friege L, Deuschl G. Falls in frequent neurological diseases--prevalence, risk factors and aetiology. J Neurol. 2004 Jan;251(1):79-84. doi: 10.1007/s00415-004-0276-8.
PubMed 14999493Koller WC, Glatt S, Vetere-Overfield B, Hassanein R. Falls and Parkinson's disease. Clin Neuropharmacol. 1989 Apr;12(2):98-105. doi: 10.1097/00002826-198904000-00003.
PubMed 2720700Gray P, Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nurs. 2000 Aug;32(4):222-8. doi: 10.1097/01376517-200008000-00006.
PubMed 10994536Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol. 2001 Nov;248(11):950-8. doi: 10.1007/s004150170047.
PubMed 11757958Paul SS, Canning CG, Sherrington C, Lord SR, Close JC, Fung VS. Three simple clinical tests to accurately predict falls in people with Parkinson's disease. Mov Disord. 2013 May;28(5):655-62. doi: 10.1002/mds.25404. Epub 2013 Feb 28.
PubMed 23450694
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sensor-supported Classification of Gait Patterns in Everyday Movement of Patients With Parkinson's Disease
- ClinicalTrials.gov ID
- NCT04054856
- Acronym / sponsor ID
- PD-GPC / 17-041
- Conditions
- Parkinson Disease
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Due to COVID-19 pandemic and new regulatory requirements
- Enrolment
- 3 participants (actual)
- Lead sponsor
- RWTH Aachen UniversityUniversity, hospital or other
- Study start
- 16 Dec 2019 (actual)
- Primary completion
- 20 Apr 2022 (actual)
- Study completion
- 6 Mar 2023 (actual)
- First posted
- 13 Aug 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Within this study we conduct long-term measurements on Parkinson patients using a three sensor IMU setup: one sensor is located at the wrist, one sensor at the belt/ in the pocket and one sensor is worn as a pendant. Before and after each long-term measurement phase (5 days within 6-8 weeks) we perform an UPDRS to identify changes in everyday life behaviour that correlate with UPDRS trends (especially part 3).
Detailed description
The aim of the study is to collect a database for the development of algorithms for the classification of everyday movement patterns of PD patients with the underlying sensor concepts. From the recorded movement data of PD patients and healthy volunteers (reference basis), characteristic features will be derived which could allow a distinction between pathological and unobtrusive non-disturbed movement patterns (e.g. on/off-state classification) and an assessment of the fall potential.
Study Timeline
The present study will be carried out in three, partly successive stages. The first two stages are measurements with the presented system during a medical examination (or afterwards) under annotation of certain motor exercises to determine the state of health of the patient or test person. In order to generate a sufficient reference database of comparable movement patterns, a series of measurements with subjects of a similar average age is carried out in parallel with the same sensor configuration and the same motor exercises. The third part of the study includes measurements in the home environment of Parkinson's patients. These measurements are used to identify the previously annotated movement patterns in the everyday life of the patient of the same previously included patient group. The individual stages of the study comprise in detail:
- Acquisition of patients/test persons The voluntary participants of this study will be recruited during the doctor's visit. The group of study participants with PD may consist of both outpatients and inpatients with Parkinson's disease (see also sub-section 4). The group of healthy volunteers is recruited from relatives or acquaintances of the patients or by request of uninvolved persons (in each case without motor impairments, see inclusion/exclusion criteria). If a patient or subject is suitable to participate in the study based on the inclusion and exclusion criteria, he or she will be informed and sign the consent form so that he or she can be included in the study. Each study participant receives an individual identification number, which is used to identify all other patient-specific documents.
- Annotation Measurements Parkinson Patients As soon as the patients have agreed to voluntarily participate in the study, the current disease status is first determined during a medical examination on the basis of a UPDRS and documented for the study evaluation. Following this, typical exercises for recording motor deficits are carried out. For this purpose, the patient is equipped with the intended sensor system and instructed in its use. The sensor system comprises three different sensor nodes, which are placed around the wrist, as a collar and in the trouser pocket. The wrist sensor is fixed to the patient's wrist by a flexible strap with a Velcro fastener. The neck sensor is positioned under the upper layer of clothing and hung around the neck by means of a special textile collar (approx. 35g). The third sensor knot has no special fastening device and is carried loosely in the trouser pocket. The attachment of the sensors is illustrated in Fig. 1. The movement data are recorded parallel to the exercises and extensively annotated according to the exercise characteristics. The exercises contain typical everyday movement patterns, which are to be identified in the further course of the study in the measurements in the domestic environment (subitem 3) and used for the evaluation of the state of health. These include among others: sit-to-stand test (STS), five-times-sit-to-stand test (5STS), sit-to-walk test (STW) or timed-up-and-go test (TUG), normal walking, climbing stairs, and handwriting.
- Annotation measurements reference group The volunteers participating in the study will be equipped with the same measuring equipment as the group of Parkinson's patients. The measurements on subjects of comparable average age serve as a reference to physiological movement sequences during the same motor exercises. On the one hand, the aim is to cover as broad a spectrum as possible for the classification of the various movement patterns. On the other hand, the data are to be used to identify pathological features that distinguish them from healthy movement patterns.
- Movement monitoring in the domestic/clinical environment of patients The group of outpatient/inpatient Parkinson's patients also take part in a long-term measurement in the domestic/clinical environment. Following the first motor examination, 5 consecutive measurements over a longer period of one day each are carried out in this section of the study. The equipment with the required measuring electronics takes place at the patient's place of residence/ in the clinic. In addition to the three previously used sensor nodes, the patient is equipped with a further node for recording on an SD card, which is also carried in the trouser pocket (approx. 35g). The SD card is written using low-level access and an internally developed protocol. This prevents third parties from accessing the transaction data. The measuring equipment is handed over on the morning of the scheduled day by a co-investigator. The patient is equipped with the system and the necessary handling of the sensor nodes is explained over the course of the day. As a daily form dependent annotated reference, the motor exercises mentioned under 2. are repeated - as far as possible in the patient's home environment / in the clinic. The patient is asked to keep an event log of the day at his own discretion and ability. On the evening of the same day, the measuring system is received again on site by a co-investigator. Any complications or questions regarding the further study protocol will be received, documented and, if necessary, reported to the study director.
- Final motor examination After completion of the third part of the study, each participant undergoes a final medical examination. This will take place following the nearest routine visit. In this examination, the motor exercises are carried out again in order to establish a basis for comparison with the initial situation (UPDRS Trend).
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patients with Morbus Parkinson | Other | Device: Body Sensor Network |
| Healthy Subjects | Other | Device: Body Sensor Network |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- patients with Parkinson's disease
- patients undergoing outpatient or inpatient treatment at the UKA
- age of majority (age > 60 years)
- written declaration of consent
- persons who are legally competent and mentally able to follow the instructions of the study personnel
Key exclusion criteria (10 listed)
- persons with currently known instabilities of the musculoskeletal system (high fall potential)
- persons with electrophobia (fear of electrical devices)
- persons wearing electrically active implants (e.g. cardiac or brain pacemakers)
- persons with neurological (except PD) or psychiatric disorders
- persons with relevant internal diseases (e.g. severe heart failure)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Body Sensor NetworkThe "Integrated Posture and Activity NEtwork by Medit Aachen (IPANEMA)" Body Sensor Network (BSN) is a wireless sensor network with several sensor nodes. A sensor node consists of a base unit equipped with different sensor modalities: Acceleration sensor, Rotation rate sensor, Air pressure sensor, Photoplethysmography (PPG, optional), Galvanic Skin Response (GSR, optional) measurement. The sensor data is transmitted via a wireless 433/868 MHz ISM band radio link to the central radio node. From there, the data is transferred via a Bluetooth connection to a laptop or PC for processing. Three sensors are attached 1) to the wrist with a flexible Velcro strap, 2) hung around the neck on a specially designed collar and 3) worn loosely in the trouser pocket without further fixation or at the belt. The respective sensors are located in a closed, ergonomically shaped housing (size 70x40x20mm^3, approx. 35g) and have no electrically conductive contact to the skin surface of the test person. | Device | Healthy Subjects, Patients with Morbus Parkinson |
Primary outcome
Disease Assessment with Wearable Movement Sensors
Time frame: 5 days -12 weeks
The Unified Parkinson's Disease Rating Scale (UPDRS) will be conducted in two consecutive clinical visits (6-12 weeks) or during an inpatient stay (5 days+). In between we conduct 5 days of long-term monitoring for each patient using a wearable movement sensor system. Outcome measures of the system (overall activity, stride time, stride variability, gait symmetry, symptom appearance, etc.) will be correlated with the UPDRS trend.
Results and safety
The study was stopped early (reason given: Due to COVID-19 pandemic and new regulatory requirements). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2023.
- Background: PubMed 17667192Dennison AC, Noorigian JV, Robinson KM, Fisman DN, Cianci HJ, Moberg P, Bunting-Perry L, Martine R, Duda J, Stern MB. Falling in Parkinson disease: identifying and prioritizing risk factors in recurrent fallers. Am J Phys Med Rehabil. 2007 Aug;86(8):621-32. doi: 10.1097/PHM.0b013e311611583.
- Background: PubMed 17588236Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, Bloem BR. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007 Oct 15;22(13):1892-900. doi: 10.1002/mds.21598.
- Background: PubMed 12023412Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):721-5. doi: 10.1136/jnnp.72.6.721.
- Background: PubMed 14999493Stolze H, Klebe S, Zechlin C, Baecker C, Friege L, Deuschl G. Falls in frequent neurological diseases--prevalence, risk factors and aetiology. J Neurol. 2004 Jan;251(1):79-84. doi: 10.1007/s00415-004-0276-8.
- Background: PubMed 2720700Koller WC, Glatt S, Vetere-Overfield B, Hassanein R. Falls and Parkinson's disease. Clin Neuropharmacol. 1989 Apr;12(2):98-105. doi: 10.1097/00002826-198904000-00003.
- Background: PubMed 10994536Gray P, Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nurs. 2000 Aug;32(4):222-8. doi: 10.1097/01376517-200008000-00006.
- Background: PubMed 11757958Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol. 2001 Nov;248(11):950-8. doi: 10.1007/s004150170047.
- Background: PubMed 23450694Paul SS, Canning CG, Sherrington C, Lord SR, Close JC, Fung VS. Three simple clinical tests to accurately predict falls in people with Parkinson's disease. Mov Disord. 2013 May;28(5):655-62. doi: 10.1002/mds.25404. Epub 2013 Feb 28.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
Recruiting
Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models
Alzheimer's Disease (AD), Frontotemporal Dementia (FTD)
Recruiting
Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease
Parkinson's Disease (PD)
Active, not recruitingPhase 2
A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease
Parkinson&Amp;#39;s Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Not yet recruiting
Cognitive-Motor Training for Gait Adaptability in Parkinson Disease
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kathrin Reetz, Prof. Dr. principal investigator
Departmet of Neurology, University Clinic Aachen, Germany
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Body Sensor Network in people with Parkinson Disease, run by RWTH Aachen University at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 3 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Due to COVID-19 pandemic and new regulatory requirements). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Disease Assessment with Wearable Movement Sensors (time frame: 5 days -12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04054856, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2023; AzTrials last refreshed its copy on 1 Nov 2026.